Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Apr 23;106(5):1377-1388.
doi: 10.1210/clinem/dgaa981.

Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL)

Sharon H Chou  1   2 , Elle M Murata  1 , Cindy Yu  1 , Jacqueline Danik  2   3 , Gregory Kotler  4 , Nancy R Cook  2   4   5 , Vadim Bubes  4 , Samia Mora  2   4   6 , Paulette D Chandler  2   4 , Deirdre K Tobias  2   4   7 , Trisha Copeland  4 , Julie E Buring  2   4   5 , JoAnn E Manson  2   4   5 , Meryl S LeBoff  1   2
Affiliations
Randomized Controlled Trial

Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL)

Sharon H Chou et al. J Clin Endocrinol Metab. .

Abstract

Context: Although observational studies show inverse associations between vitamin D status and body weight/adiposity, there are few large randomized controlled trials (RCTs) investigating this relationship.

Objective: To determine whether vitamin D3 supplementation lowers weight or improves body composition.

Design: The VITamin D and OmegA-3 TriaL (VITAL) was a double-blinded, placebo-controlled RCT including 25 871 US adults. This ancillary study was completed in a sub-cohort that underwent body composition assessments at baseline and 2-year follow-up (89% retention).

Setting: Harvard Clinical and Translational Science Center in Boston.

Participants: 771 participants (men ≥ 50 and women ≥ 55 years).

Interventions: 2 × 2 factorial design of supplemental vitamin D3 (2000 IU/day) and/or omega-3 fatty acids (1 g/day).

Main outcome measures: Endpoints were 2-year changes in weight, body mass index (BMI), waist circumference, and total and/or regional fat and lean tissue measures determined by dual-energy X-ray absorptiometry. Effect modification by clinical variables and total and free 25-hydroxyvitamin D (25[OH]D) levels was explored.

Results: There were no effects of supplemental vitamin D3vs placebo on weight, BMI, or measures of adiposity and lean tissue. Effects did not vary by sex, race/ethnicity, fat mass index, or baseline total or free 25(OH)D levels. Vitamin D3 supplementation did slightly improve body fat percentage in participants with normal BMI at baseline, but not in the overweight or obese (P for interaction = 0.04).

Conclusions: Daily vitamin D3 supplementation vs placebo in the general older population did not improve weight or body composition. Whether supplemental vitamin D3 may benefit individuals with normal BMI warrants further study.

Trial registration: ClinicalTrials.gov NCT01747447 NCT01169259 NCT01704859.

Keywords: adiposity; body composition; body mass index; lean tissue; vitamin D; weight.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Percentage changes over 2 years in body composition measures. Outcomes of adipose and lean tissues were assessed by dual-energy X-ray absorptiometry. Abbreviations: ALM, appendicular lean mass; BMI, body mass index; FMI, fat mass index; LMI, lean mass index; VAT, visceral adipose tissue.
Figure 2.
Figure 2.
Percentage changes over 2 years in body composition measures. (A) In participants with BMI < 25kg/m2, (B) in participants with BMI 25-<30kg/m2, and (C) in participants with BMI > 30kg/ m2. Outcomes of adipose and lean tissues were assessed by dual-energy X-ray absorptiometry. Abbreviations: BMI, body mass index; FMI, fat mass index; VAT, visceral adipose tissue.
See this image and copyright information in PMC

References

    1. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA. 2018;319(16):1723-1725. - PMC - PubMed
    1. Ward ZJ, Bleich SN, Cradock AL, et al. . Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440-2450. - PubMed
    1. Herrick KA, Storandt RJ, Afful J, et al. . Vitamin D status in the United States, 2011-2014. Am J Clin Nutr. 2019;110(1):150-157. - PMC - PubMed
    1. Jun S, Cowan AE, Bhadra A, et al. . Older adults with obesity have higher risks of some micronutrient inadequacies and lower overall dietary quality compared to peers with a healthy weight, National Health and Nutrition Examination Surveys (NHANES), 2011–2014. Public Health Nutr. 2020;23(13):2268-2279. . - PMC - PubMed
    1. Ceglia L, Nelson J, Ware J, et al. ; Diabetes Prevention Program Research Group . Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program. Eur J Nutr. 2017;56(1):161-170. - PMC - PubMed

Publication types

MeSH terms

Associated data